By Marianne Apostolides
Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.
Read on neo.life
CLEAR ALL
Roland Griffiths' psilocybin experiments have produced striking evidence for therapeutic uses of hallucinogens.
1
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
Scientists Roland Griffiths and Matthew Johnson sit down with journalist Anderson Cooper to discuss the promise of psychedelics as a form of treatment for anxiety, depression, addiction, and more.
We spoke about his research with psilocybin, his interest in spiritual experiences, and how psychedelics may provide help for people who are dying.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
A new brain-scan study helps explain how psilocybin works—and why it holds promise as a treatment for depression, addiction and post-traumatic stress.
How magic mushrooms expand consciousness.
2
Psychedelic drugs are making a quiet comeback, as a smattering of recent studies have demonstrated their medicinal potential. The latest finding suggests it is time to revisit LSD as a treatment for addiction.
In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...